Total submissions: 2
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Ambry Genetics | RCV005513177 | SCV006180823 | uncertain significance | Inborn genetic diseases | 2025-04-24 | criteria provided, single submitter | clinical testing | The c.4073A>G (p.E1358G) alteration is located in exon 11 (coding exon 11) of the TRIP11 gene. This alteration results from a A to G substitution at nucleotide position 4073, causing the glutamic acid (E) at amino acid position 1358 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
| Labcorp Genetics |
RCV001959796 | SCV002216467 | uncertain significance | Achondrogenesis, type IA | 2021-09-24 | criteria provided, single submitter | clinical testing |